Clinical trial site training is supposed to do one essential thing: Prepare site staff to execute a clinical trial safely, accurately, and consistently. Too often, it does something else. It asks experienced professionals to prove (again and again) that they know what they already know.
Sites can spend hours on training for each study, even when much of the content is duplicated across trials and systems. Sponsors and CROs also face their own burdens, in tracking completion, reconciling records, and preparing for audits across multiple systems and formats.
The result is a process that is heavily documentation-based, light on reuse, and often only loosely connected to the real goal of protocol execution.
A training model ready for modernization
At our most recent Site-Sponsor Consortium meeting this spring, we focused on a simple but important question: How can site training become more risk-based, more reusable, and more connected to actual study readiness?
The Consortium—an equally weighted coalition of sites, sponsors and CROs facilitated by Advarra—is building on the Society for Clinical Research Sites’ (SCRS) recent work around reducing site burden.
Our goal is not to eliminate training. It is to help the industry stop repeating low-value content and focus more attention on the training that truly matters for each study.
A regulatory opening in plain sight
Global regulatory bodies have a well-documented perspective when it comes to site training. ICH E6(R3) and international regulatory bodies emphasize that personnel must be qualified by education, training, and experience for their assigned tasks. They also advocate a risk-based approach in which personnel should be qualified for assigned tasks, without prescribing repeated generic training for every new study when adequate evidence of qualification already exists.
This creates an opening. If adequate evidence of qualification is available, foundational training may be treated as reusable.
A practical training model
A better model begins by separating reusable foundations training from study-specific instruction. Foundational training may include GCP/HSP training and core platform-level skills such as EDC navigation, data entry mechanics, and query handling. When there is reasonable evidence that site personnel have already completed this training or can demonstrate current competency, it should not have to be repeated simply because a new study begins.
Study-specific training can then focus solely on what is new, different, or critical to managing risk in a particular trial, for example, study workflows, safety requirements, CRF completion expectations, and role-specific responsibilities. Reducing redundant platform training is more than an efficiency goal; it helps preserve attention for the study-specific instruction that matters most.
Why EDC the right first test case
Within this architecture, EDC is the ideal starting point for training reciprocity. The Consortium selected this as its first test project because of the potential impact: EDC is used in most studies, touches multiple site roles, and is frequently repeated even when the same platform is used across trials. It also lends itself to a clear distinction between reusable platform-level skills and study-specific requirements.
In many cases, the necessary infrastructure already exists, including vendor training modules, completion records, user histories, certificates, and waiver mechanisms. The challenge is not technology, but inconsistent processes, limited trust in prior evidence, and the lack of shared criteria for reciprocity.
A practical first step
The Consortium is now working toward practical tools that sponsors and CROs can use to operationalize this model, including an EDC Reciprocity Starter Kit. That work will include approaches for defining acceptable prior training, applying role-based training matrices, documenting evidence consistently, and identifying where reusable platform training can be recognized without compromising study readiness.
This effort is not intended to address every training challenge at once. Rather, it aims to establish a practical starting point: one that enables sponsors, CROs, vendors, and sites to align around a more consistent, defensible, and efficient approach to assessing readiness.
The emerging principle is simple. Reuse what is already known and train staff only on what is new, different, or risk-critical for the study.
That shift can reduce burden, improve the site experience, support faster startup, and bring site training closer to what it was always meant to be: a tool for safe, effective protocol execution, not just another administrative hurdle.
What’s next: Site Initiation Visit training
The Site-Sponsor Consortium is now expanding its attention to Site Initiation Visit (SIV) training. Look out for our three-part blog series later this summer, where we’ll explore opportunities to improve study readiness and ensure site feasibility.
